Suzhou Genhouse Bio Co., Ltd.
Suzhou Genhouse Bio Co., Ltd. has 1 licensing announcement in this dataset, dated 2026-02-13.
- Country / operating region
- China
- Ticker
- 查無
- Headquarters
- Suzhou, China
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.genhousebio.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| GH31 | MAT2A | small molecule | IND-cleared; Phase I planned | 2026-02-13 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-02-13 | Gilead Sciences, Inc. | GH31 | USD 80m | 查無 | ≤ USD 1450m | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Gilead Sciences, Inc. | Worldwide | Tiered royalties on net sales up to low double digits. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無